June Almenoff
Förmögenhet: 90 121 $ per 2026-05-31
Förmögenhet: 90 121 $ per 2026-05-31
June Sherie Almenoff is currently an Independent Director at Tenax Therapeutics, Inc. since 2021 and an Independent Director at Actinium Pharmaceuticals, Inc. since 2024.
Former positions include President, CEO, Director & Chief Medical Officer at Furiex Pharmaceuticals, Inc. from 2010 to 2014; Executive Chairman at RDD Pharma Ltd. from 2015 to 2018; Independent Non-Executive Director at TiGenix NV from 2016 to 2018; Director at Kurome Therapeutics, Inc. from 2020 to 2021; Independent Director at Ohr Pharmaceutical, Inc. from 2013 to 2019; Independent Director at Brainstorm Cell Therapeutics, Inc. from 2017 to 2023; Independent Director at Avalo Therapeutics, Inc. from 2021 to 2025; Vice President-Clinical Safety Organization at GlaxoSmithKline LLC from 1997 to 2010; Chief Operating & Medical Officer at 9 Meters Biopharma, Inc. in 2018; and Chief Medical Officer at RedHill Biopharma Ltd. Membership in the Infectious Diseases Society of America is noted.
Education includes undergraduate studies at Smith College and a doctorate from Icahn School of Medicine at Mount Sinai.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
AVALO THERAPEUTICS INC 0,01 % | 2025-06-17 | 4 167 ( 0,01 % ) | 66 464 $ | 2026-05-31 |
TENAX THERAPEUTICS, INC. 0,01 % | 2026-04-08 | 1 993 ( 0,01 % ) | 23 657 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2021-02-25 |
| ACTINIUM PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2024-11-01 |
| Företag | Position | Slut |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2025-10-01 |
| BRAINSTORM CELL THERAPEUTICS INC. | Direktör/Styrelseledamot | 2023-12-01 |
Kurome Therapeutics, Inc.
Kurome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies that target cancer cells | Direktör/Styrelseledamot | 2021-01-01 |
Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pharmaceuticals for the treatment of serious and unmet medical needs | Direktör/Styrelseledamot | 2019-07-12 |
| 9 METERS BIOPHARMA, INC. | Verksamhetschef | 2018-11-16 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 15 |
|---|---|
Tenax Therapeutics, Inc.
Tenax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes pharmaceutical therapeutic products | Health Technology |
Brainstorm Cell Therapeutics, Inc.
Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
TiGenix NV
TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
Furiex Pharmaceuticals, Inc.
Furiex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug development collaboration company | Health Technology |
Smith College
Smith College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services Operates as a medical association representing physicians, scientists, and other healthcare professionals | Commercial Services |
RDD Pharma Ltd.
RDD Pharma Ltd. Medical SpecialtiesHealth Technology Develops pharmacological treatments for diseases of the anorectal region | Health Technology |
Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pharmaceuticals for the treatment of serious and unmet medical needs | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
RedHill Biopharma Ltd.
RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
9 Meters Biopharma, Inc.
9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Kurome Therapeutics, Inc.
Kurome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies that target cancer cells | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån